Sriramulu S, Thoidingjam S, Siddiqui F, Brown S, Movsas B, Walker E
Biomolecules. 2024; 14(6).
PMID: 38927028
PMC: 11202206.
DOI: 10.3390/biom14060625.
Wang J, Chen Y, Li S, Liu W, Zhou X, Luo Y
J Clin Invest. 2023; 134(1).
PMID: 37934606
PMC: 10760972.
DOI: 10.1172/JCI172137.
Chen X, Yang C, Wang W, He X, Sun H, Lyu W
Front Genet. 2023; 14:1025163.
PMID: 36911389
PMC: 9998954.
DOI: 10.3389/fgene.2023.1025163.
Yan X, Liu S, Liu C
Onco Targets Ther. 2022; 15:1355-1368.
PMID: 36388157
PMC: 9662021.
DOI: 10.2147/OTT.S380016.
Funnell T, OFlanagan C, Williams M, McPherson A, McKinney S, Kabeer F
Nature. 2022; 612(7938):106-115.
PMID: 36289342
PMC: 9712114.
DOI: 10.1038/s41586-022-05249-0.
Potential Prognostic Biomarkers of NIMA (Never in Mitosis, Gene A)-Related Kinase (NEK) Family Members in Breast Cancer.
Anuraga G, Wang W, Phan N, An Ton N, Ta H, Prayugo F
J Pers Med. 2021; 11(11).
PMID: 34834441
PMC: 8625415.
DOI: 10.3390/jpm11111089.
Mitotic Errors Promote Genomic Instability and Leukemia in a Novel Mouse Model of Fanconi Anemia.
Edwards D, Mitchell D, Abdul-Sater Z, Chan K, Sun Z, Sheth A
Front Oncol. 2021; 11:752933.
PMID: 34804941
PMC: 8602820.
DOI: 10.3389/fonc.2021.752933.
Intrinsic Disorder and Phosphorylation in BRCA2 Facilitate Tight Regulation of Multiple Conserved Binding Events.
Julien M, Ghouil R, Petitalot A, Caputo S, Carreira A, Zinn-Justin S
Biomolecules. 2021; 11(7).
PMID: 34356684
PMC: 8301801.
DOI: 10.3390/biom11071060.
Mitotic checkpoint defects: en route to cancer and drug resistance.
Sarkar S, Sahoo P, Mahata S, Pal R, Ghosh D, Mistry T
Chromosome Res. 2021; 29(2):131-144.
PMID: 33409811
DOI: 10.1007/s10577-020-09646-x.
Molecular contribution of BRCA1 and BRCA2 to genome instability in breast cancer patients: review of radiosensitivity assays.
Sadeghi F, Asgari M, Matloubi M, Ranjbar M, Karkhaneh Yousefi N, Azari T
Biol Proced Online. 2020; 22:23.
PMID: 33013205
PMC: 7528506.
DOI: 10.1186/s12575-020-00133-5.
The role of BRCA1/2 in hereditary and familial breast and ovarian cancers.
Hawsawi Y, Al-Numair N, Sobahy T, Al-Ajmi A, Al-Harbi R, Baghdadi M
Mol Genet Genomic Med. 2019; 7(9):e879.
PMID: 31317679
PMC: 6732305.
DOI: 10.1002/mgg3.879.
Genotypic and Phenotypic Variables Affect Meiotic Cell Cycle Progression, Tumor Ploidy, and Cancer-Associated Mortality in a -Mutant Zebrafish Model.
Mensah L, Ferguson J, Shive H
J Oncol. 2019; 2019:9218251.
PMID: 30930946
PMC: 6413366.
DOI: 10.1155/2019/9218251.
BRE/BRCC45 regulates CDC25A stability by recruiting USP7 in response to DNA damage.
Biswas K, Philip S, Yadav A, Martin B, Burkett S, Singh V
Nat Commun. 2018; 9(1):537.
PMID: 29416040
PMC: 5803202.
DOI: 10.1038/s41467-018-03020-6.
Single-molecule localization microscopy reveals molecular transactions during RAD51 filament assembly at cellular DNA damage sites.
Haas K, Lee M, Esposito A, Venkitaraman A
Nucleic Acids Res. 2018; 46(5):2398-2416.
PMID: 29309696
PMC: 5861458.
DOI: 10.1093/nar/gkx1303.
Paradoxical delay of senescence upon depletion of BRCA2 in telomerase-deficient worms.
Kwon M, Min J, Jeon H, Hwang K, Kim C, Lee J
FEBS Open Bio. 2016; 6(10):1016-1024.
PMID: 27761361
PMC: 5055038.
DOI: 10.1002/2211-5463.12109.
DNA repair, genome stability and cancer: a historical perspective.
Jeggo P, Pearl L, Carr A
Nat Rev Cancer. 2015; 16(1):35-42.
PMID: 26667849
DOI: 10.1038/nrc.2015.4.
Connecting the speckles: Splicing kinases and their role in tumorigenesis and treatment response.
Corkery D, Holly A, Lahsaee S, Dellaire G
Nucleus. 2015; 6(4):279-88.
PMID: 26098145
PMC: 4615201.
DOI: 10.1080/19491034.2015.1062194.
Induction of centrosome amplification by formaldehyde, but not hydroquinone, in human lymphoblastoid TK6 cells.
Ji Z, McHale C, Bersonda J, Tung J, Smith M, Zhang L
Environ Mol Mutagen. 2015; 56(6):535-44.
PMID: 25821186
PMC: 6529207.
DOI: 10.1002/em.21947.
Brca2 deficiency leads to T cell loss and immune dysfunction.
Jeong J, Jo A, Park P, Lee H, Lee H
Mol Cells. 2015; 38(3):251-8.
PMID: 25666348
PMC: 4363725.
DOI: 10.14348/molcells.2015.2302.
ATR inhibition preferentially targets homologous recombination-deficient tumor cells.
Krajewska M, Fehrmann R, Schoonen P, Labib S, de Vries E, Franke L
Oncogene. 2014; 34(26):3474-81.
PMID: 25174396
DOI: 10.1038/onc.2014.276.